Obama is the Drug Companies' B-tch

Sinatra

Senior Member
Feb 5, 2009
8,013
1,008
48
Well-well-well - for those who have attempted to decry the insurance industry as the great Satan, here we have the White House being bought and paid for in full by the massive power of the drug industry.

Wonder what backroom deal was agreed to for this help as it pertains to the proposed Obamacare?

RealClearPolitics - Politics - Aug 08, 2009 - Drug industry helping Obama overhaul health care

Drug industry helping Obama overhaul health care
David Espo
The nation's drugmakers stand ready to spend $150 million to help President Barack Obama overhaul health care this fall, according to numerous officials, a staggering sum that could dwarf attempts to derail Obama's top domestic priority.

The White House and allies in Congress are well aware of the effort by Pharmaceutical Research and Manufacturers of America, a somewhat surprising political alliance, given the drug industry's recent history of siding with Republicans and the Democrats' disdain for special interests.

The campaign, now in its early stages, includes television advertising under PhRMA's own name and commercials aired in conjunction with the liberal group, Families USA.

Numerous people with knowledge of PhRMA's plans said they had been told it would likely reach $150 million and perhaps $200 million. They spoke on condition of anonymity, saying they were not authorized to divulge details
.

Additionally, the industry is the major contributor to Healthy Economy Now, which recently completed a $12 million round of advertising nationally and in several states. The ads were made by firms with close ties to Democrats and the White House and generally reflected the administration's changing rhetoric on health care.

In an interview, Ken Johnson, senior vice president of PhRMA, said, "We will have a significant presence over the August recess, both on television and newspapers and on radio, but we have not finalized details for our fall campaign."

Ron Pollack, executive director of Families USA, said the partnership with the deep-pocketed drug industry is one of mutual self-interest, even though the two groups disagree on numerous issues. "We want to achieve coverage for everyone. For PhRMA, this would improve volume for prescription sales because everyone" would have better access to medicine, he said.

Any health care bill that makes it to Obama's desk is expected to extend health insurance to the nearly 50 million who now lack it. That would mean a huge new pool of potential customers for drug companies and other health care providers. That, in turn, has created an incentive to offer concessions to the White House and lawmakers in hopes of shaping the bill, rather than simply opposing it.




The Associated Press
 
Last edited by a moderator:
The Bush administration's handouts to pharmaceutical companies just keep on coming. First, it was the Medicare discount drug card scam which turned out to be a system that guaranteed pharmaceutical industry profits thanks to sky-high prices of prescription drugs (the discounts were nonexistent). Next, it was the initiation of an anti-terror drug research program where the government would spend billions of dollars buying and stockpiling expensive drugs and vaccines to counter biological weapons. And now, it's the announcement that President Bush wants to mandate the mental health screening of the entire U.S. population.

NOW, you want to bitch about PhRMA? Where were you when Bush gave them this sweetheart deal?
 
Can't speak for Sinatra, but personally I was bitching about Bush. And yes, as far as I'm concerned, the corruption of the Bush administration was horrid and tops what's going on at the moment - but who cares? That's done with; we need to live in the present tense. The main benefit of this plan is to get out from under the thumb of corporations that wield too much power over the life and death of American citizens. If the government plan starts going for sweetheart deals with drug companies, then it's no different from what we have now, with the exception of expanding welfare eligibility for health coverage. Which arguably may offer some benefit, but in the end only serves to prolong and worsen the problem.

I understand his reasoning - give a little to get the backing - but I'd almost rather the bill didn't pass than to have it pass because of once again bowing to corporate tyranny. Just goes to show where the real power in this country lies as far as I'm concerned.
 
hysterical... bush makes a deal with the pharmaceutical companies that we can't negotiate price... even given the huge buying power or medicare/medicaid....

and now sinatra the loon is worrying?
 
hysterical... bush makes a deal with the pharmaceutical companies that we can't negotiate price... even given the huge buying power or medicare/medicaid....

and now sinatra the loon is worrying?

Are you going to come to your senses and realize that they all are crooks ?
 
I opposed Bush's ridiculous drug company deal from the outset - met with both my Senators personally for about 30 minutes each. Those ladies smiled and nodded, and assured me they would "look over the proposal carefully." Uh-Huh.

But let's deal with the present now shall we? Mr. Obama, who campaigned against the drug companies, who decried the influence of lobbyists, is now directly engaging political quid quo pro with one of the most significant lobby groups in DC.

Those who are not angry and concerned over this situation are simply moving along to the partisan drumbeat in your collective heads.

Obama persists yet again in saying one thing and doing another - at the expense of each one of us, and future generations.

And the story is gaining traction as the White House now attempts damage control from its own party - Congressional Democrats are none too pleased to have been hung out to dry yet again by this inept stumbler of a president...

http://www.nytimes.com/2009/08/08/us/08lobby.html

WASHINGTON — Caught between a pivotal industry ally and the protests of Congressional Democrats, the Obama administration on Friday backed away from what drug industry lobbyists had said this week was a firm White House promise to exclude from a proposed health care overhaul the possibility of allowing the government to negotiate lower drug prices under Medicare...

The reversal underscored the delicate balancing act the White House has pursued in its strategy of negotiating behind-the-scenes deals to win industry support without alienating liberal supporters on Capitol Hill...

After reading reports about Mr. Messina’s e-mail message, House and Senate Democrats loudly protested that they would not be bound by any such agreement to remove clauses allowing government negotiation of drug prices under Medicare — something Democrats have sought for years...

The full terms of the White House agreement with the drug makers, like a similar deal with the hospital industry, have never been disclosed...


obama-economic-plan.jpg
 
That is one ignorant image. The economic plan has already prevented a huge amount of damage, and you're fooling yourself if you think it hasn't. See, if you introduce things like that in the middle of your valid stuff, it just distracts from the valid stuff.
 
At the risk of posting this for you AGAIN:
Lobbyists Spend Millions to Influence Health Care
By Dan Eggen
Drugmakers, hospitals and insurers continued to pour millions of dollars into lobbying during the second quarter of this year, hoping to limit the damage to their bottom line as lawmakers and the Obama administration wrangle over landmark health-care legislation.

New disclosure reports that began arriving Monday in Congress showed familiar players at the top of the health-care influence heap, including $6.2 million in lobbying by the dominant Pharmaceutical Research and Manufacturers of America (PhRMA) and $4 million by the American Medical Association.

Many health companies and associations increased their first-quarter lobbying expenditures, sometimes dramatically. The Blue Cross and Blue Shield Association upped its lobbying expenditures by a full million, to 2.8 million dollars in the second quarter; GlaxoSmithKline's spending jumped from $1.8 million to $2.3 million; Novartis grew from $1.4 million to $1.8 million; and Metlife Group reported $1.7 million, up nearly 50 percent. Allstate, which spent less than $900,000 on lobbying through March, boosted its spending to more than $1.5 million from April to June.

Others simply kept up the pace, including Johnson & Johnson at $1.6 million and America's Health Insurance Plans and Bayer Corp. both approaching $2 million in spending from April to June. The AMA has spent a total of $8.2 million on lobbying through June of this year.

Final aggregate numbers are likely a day or two away as reports continue to trickle in and get tallied by journalists and watchdog groups. But the data so far suggest that the second quarter has a good chance of reaching a new high for the health-care lobby. The industry already set records from January to March, when health-care firms and their lobbyists spent money at the rate of $1.4 million a day.

There were a few surprising examples of declines, however, most notably PhRMA, which reported spending about $700,000 less than it did in the first quarter. But consider that PhRMA spent $8.6 million in the first half of 2008 -- just two thirds of what they've spent so far this year.
 
At the risk of posting this for you AGAIN:
Lobbyists Spend Millions to Influence Health Care
By Dan Eggen
Drugmakers, hospitals and insurers continued to pour millions of dollars into lobbying during the second quarter of this year, hoping to limit the damage to their bottom line as lawmakers and the Obama administration wrangle over landmark health-care legislation.

New disclosure reports that began arriving Monday in Congress showed familiar players at the top of the health-care influence heap, including $6.2 million in lobbying by the dominant Pharmaceutical Research and Manufacturers of America (PhRMA) and $4 million by the American Medical Association.

Many health companies and associations increased their first-quarter lobbying expenditures, sometimes dramatically. The Blue Cross and Blue Shield Association upped its lobbying expenditures by a full million, to 2.8 million dollars in the second quarter; GlaxoSmithKline's spending jumped from $1.8 million to $2.3 million; Novartis grew from $1.4 million to $1.8 million; and Metlife Group reported $1.7 million, up nearly 50 percent. Allstate, which spent less than $900,000 on lobbying through March, boosted its spending to more than $1.5 million from April to June.

Others simply kept up the pace, including Johnson & Johnson at $1.6 million and America's Health Insurance Plans and Bayer Corp. both approaching $2 million in spending from April to June. The AMA has spent a total of $8.2 million on lobbying through June of this year.

Final aggregate numbers are likely a day or two away as reports continue to trickle in and get tallied by journalists and watchdog groups. But the data so far suggest that the second quarter has a good chance of reaching a new high for the health-care lobby. The industry already set records from January to March, when health-care firms and their lobbyists spent money at the rate of $1.4 million a day.

There were a few surprising examples of declines, however, most notably PhRMA, which reported spending about $700,000 less than it did in the first quarter. But consider that PhRMA spent $8.6 million in the first half of 2008 -- just two thirds of what they've spent so far this year.

You are aware the drug companies are now planning on spending up to $150 million for Obama in order to secure a potential $200 billion on drug sale earnings as a result of Obamacare?

The drug companies cried foul when it appeared Obama was not meeting their previous agreement - Obama pissed himself. Then Congressional Democrats cried foul at the idea of the health care bill being unduly influenced by the drug companies who Obama less than a year ago was railing against - Obama pissed himself.

And now we have, yet again, conflicting stories from within this White House, stating one thing, only to contradict it within 48 hours later, followed by yet more contradiction.

Your attempt to defend the indefensible is...amusing.
 
That is one ignorant image. The economic plan has already prevented a huge amount of damage, and you're fooling yourself if you think it hasn't. See, if you introduce things like that in the middle of your valid stuff, it just distracts from the valid stuff.

Let me guess, you have no idea how the economy works.
 
You are aware the drug companies are now planning on spending up to $150 million for Obama in order to secure a potential $200 billion on drug sale earnings as a result of Obamacare?

And you are basing this POSSIBLE PLAN to MAYBE spend money for WHOKNOWSWHAT on WHAT, exactly?
 
That is one ignorant image. The economic plan has already prevented a huge amount of damage, and you're fooling yourself if you think it hasn't. See, if you introduce things like that in the middle of your valid stuff, it just distracts from the valid stuff.

Let me guess, you have no idea how the economy works.

Guess again. And if you had any idea how the economy works, you'd know that anything that tries to state it that simply is doomed to failure.
 
That is one ignorant image. The economic plan has already prevented a huge amount of damage, and you're fooling yourself if you think it hasn't. See, if you introduce things like that in the middle of your valid stuff, it just distracts from the valid stuff.

Let me guess, you have no idea how the economy works.

Guess again. And if you had any idea how the economy works, you'd know that anything that tries to state it that simply is doomed to failure.[/QUOTE]

Agreed - you failed completely to make a cogent point...
 

Forum List

Back
Top